Pfizer (NYSE:PFE – Get Free Report)‘s stock had its “buy” rating restated by research analysts at Guggenheim in a research ...

Market indexes have been falling as investors are beginning to assume President Trump will make good on repeated promises to ...

We recently published a list of 10 Stocks Market Experts are Talking About These Days. In this article, we are going to take ...

With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. | After charting similar moves ...

We recently published a list of 10 Most Undervalued S&P 500 Stocks to Buy Now. In this article, we are going to take a look ...

Additionally, US exchanges like the New York Stock Exchange and Nasdaq are among the ... Number of Hedge Fund Holders: 80 Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets ...

Pfizer Inc. (PFE), headquartered in New York, discovers ... experiencing some fluctuations. The stock is trading below its 200-day moving average since November 2024. PFE has seen ...

We can refer to full-year 2019 revenue of about $51 billion and the company's comments about potential revenue of more than $80 billion in non-COVID revenue by 2030. This represents an increase of ...

Pfizer (PFE) stock gains as company appoints James List, a former J&J (JNJ) executive as Chief Internal Medicine Officer to ...